Cargando…
Celecoxib Suppresses NF-κB p65 (RelA) and TNFα Expression Signaling in Glioblastoma
Background: Glioblastoma (GBM) harbors significant genetic heterogeneity, high infiltrative capacity, and patterns of relapse following many therapies. The expression of nuclear factor kappa-B (NF-κB p65 (RelA)) and signaling pathways is constitutively activated in GBM through inflammatory stimulati...
Autores principales: | Ahsan, Hina, Malik, Shaukat Iqbal, Shah, Fawad Ali, El-Serehy, Hamed A., Ullah, Amin, Shah, Zafar Abbas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607796/ https://www.ncbi.nlm.nih.gov/pubmed/37892820 http://dx.doi.org/10.3390/jcm12206683 |
Ejemplares similares
-
Thr(435) phosphorylation regulates RelA (p65) NF-κB subunit transactivation
por: O'Shea, John M., et al.
Publicado: (2010) -
NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB
por: Kabacaoglu, Derya, et al.
Publicado: (2019) -
NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells
por: Han, Dongfeng, et al.
Publicado: (2015) -
Enterovirus 71 2C Protein Inhibits NF-κB Activation by Binding to RelA(p65)
por: Du, Haiwei, et al.
Publicado: (2015) -
An incoherent feedforward loop interprets NFκB/RelA dynamics to determine TNF‐induced necroptosis decisions
por: Oliver Metzig, Marie, et al.
Publicado: (2020)